Resource Center
Welcome to our resource center, your comprehensive hub for valuable information and insights in the field of diagnostic testing and precision medicine. As a leading global provider of specialized laboratory testing services, we understand the importance of staying informed and up-to-date in the ever-evolving world of healthcare diagnostics. The resource center is available to empower healthcare professionals, researchers, and industry stakeholders by offering a wide range of educational materials including; whitepapers, case studies, podcasts, videos, e-books and webinars. Whether you are seeking in-depth knowledge about cutting-edge diagnostic technologies, exploring emerging trends in precision medicine, or looking for practical guidance on test interpretation and patient care, our resources center is your go-to destination for reliable and relevant information. Join us on this journey of discovery and innovation as we strive to enhance patient outcomes and advance the field of diagnostic testing together.
Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Consensus Definitions & Up-to-Date Management
In this post, we emphasize the critical need for nontuberculous mycobacteria (NTM) and fungal testing for patients undergoing CAR T-cell therapy. While this innovative treatment has shown effectiveness against certain cancers, it significantly suppresses the immune system, making patients more vulnerable to opportunistic infections...
Watch the on-demand webinar where we’ll explore the significance of TTV in clinical settings and its potential as an objective aid for modifying immunosuppression in transplant recipients. Discover the latest diagnostic tools and methodologies that utilize TTV, along with real-world examples showcasing its impact on patient outcomes. The session will also include an interactive Q&A. Don’t miss this opportunity to enhance your understanding of TTV in transplant care!
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.